H Peter Rodemann Selected Research

H Peter Rodemann Research Topics

Disease

27	Neoplasms (Cancer) 12/2019 - 06/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016 - 07/2008
4	Carcinoma (Carcinomatosis) 10/2011 - 02/2005
3	Glioblastoma (Glioblastoma Multiforme) 10/2011 - 05/2005
3	Fibrosis (Cirrhosis) 12/2004 - 03/2004
2	Breast Neoplasms (Breast Cancer) 03/2019 - 01/2016
2	Retinoblastoma (Glioblastoma, Retinal) 01/2017 - 11/2016
2	Lung Neoplasms (Lung Cancer) 07/2016 - 07/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2014 - 10/2003
2	Squamous Cell Carcinoma of Head and Neck 03/2014 - 09/2013
1	Bone Fractures (Bone Fracture) 05/2022
1	Colonic Neoplasms (Colon Cancer) 12/2019
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Hypoxia (Hypoxemia) 09/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2013
1	Adenocarcinoma of Lung 10/2008
1	Cicatrix (Scar) 01/2008
1	Bronchogenic Carcinoma 02/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2005
1	Radiation Pneumonitis 09/2004
1	Radiation Injuries (Radiation Sickness) 09/2004
1	Starvation 10/2003

Drug/Important Bio-Agent (IBA)

13	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 10/2003
6	Proteins (Proteins, Gene)FDA Link 05/2022 - 06/2003
6	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2017 - 07/2008
5	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 03/2019 - 07/2008
5	ErbB Receptors (EGF Receptor)IBA 12/2011 - 02/2005
3	Phosphotransferases (Kinase)IBA 12/2015 - 10/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2015 - 07/2006
3	LigandsIBA 03/2014 - 08/2007
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2004 - 03/2004
3	CytokinesIBA 12/2004 - 03/2004
2	Protein Isoforms (Isoforms)IBA 12/2019 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 05/2013
2	AmphiregulinIBA 03/2014 - 08/2007
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2014 - 11/2010
1	Small Interfering RNA (siRNA)IBA 12/2019
1	plastinIBA 10/2019
1	Cytotoxins (Cytolysins)IBA 11/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	NFATC Transcription FactorsIBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 11/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2016
1	PI103IBA 07/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2016
1	4-trifluoromethylsalicylic acid (HTB)IBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2015
1	Chloroquine (Aralen)FDA LinkGeneric 09/2015
1	Cisplatin (Platino)FDA LinkGeneric 05/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2014
1	Cetuximab (Erbitux)FDA Link 09/2013
1	Adenosine Triphosphate (ATP)IBA 05/2013
1	Epidermal Growth Factor (EGF)IBA 11/2010
1	DNA-Activated Protein KinaseIBA 07/2008
1	Celecoxib (Celebrex)FDA Link 01/2008
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2008
1	Growth Factor ReceptorsIBA 11/2007
1	Mitogen-Activated Protein KinasesIBA 08/2007
1	Mitogen-Activated Protein Kinase 3IBA 08/2007
1	EnzymesIBA 08/2007
1	Phosphatidylinositols (Phosphatidylinositol)IBA 07/2006
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2005
1	Cyclin BIBA 05/2005
1	Tyrosine Kinase InhibitorsIBA 02/2005
1	BIBX 1382BSIBA 02/2005
1	Biological ProductsIBA 09/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2003
1	RetinoidsIBA 06/2003
1	Messenger RNA (mRNA)IBA 06/2003
1	retinoic acid receptor betaIBA 06/2003

Therapy/Procedure

13	Radiotherapy 10/2019 - 06/2003
3	Therapeutics 12/2015 - 12/2004
1	Intravitreal Injections 11/2016
1	Drug Therapy (Chemotherapy) 03/2008
1	Artificial Skin 01/2008
1	Aftercare (After-Treatment) 05/2005
1	Chemoradiotherapy 03/2004